Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Acorda Therapeutics Inc (NASDAQ:ACOR)

34.53
Delayed Data
As of Aug 04
 -0.21 / -0.60%
Today’s Change
28.52
Today|||52-Week Range
45.45
-15.51%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Operating ActivitiesNet Income / Starting Line12.0M330.0K-3.1M--
 
 
 
 
Depreciation1.8M3.1M3.7M--
 
 
 
 
Total Other Cash Flow10.8M20.5M12.9M--
 
 
 
 
Funds From Operations29.1M17.2M11.5M--
 
 
 
 
Funds From/For Other Operating Expenses-9.5M3.6M15.8M--
 
 
 
 
Net Cash Flow - Operating Activities38.6M13.6M-4.4M--
 
 
 
 
 
InvestingIncrease In Investments-316.5M0.00-169.6M--
 
 
 
Decrease In Investments55.0M587.0M56.3M--
 
 
 
 
Capital Expenditures-940.0K-2.8M-2.6M--
 
 
 
 
Net Assets From Acquisitions 0.00-476.2M0.00--
 
 
Net Cash Flow Investing-262.8M107.0M-116.0M--
 
 
 
 
 
FinancingShort Term Borrowings0.000.00-41.0K--
 
 
Long Term Borrowings-75.0K0.000.00--
 
 
Long Term Debt Reduction-92.0K-110.0K-110.0K--
 
 
 
 
Net Proceeds Stock Sale3.3M8.4M4.7M--
 
 
 
 
Common Preferred Redeemed0.000.000.00----
Common Dividends----------
Cash Dividends Paid - Total0.000.000.00----
Other Sources - Financing0.000.000.00----
Other Uses - Financing0.000.000.00----
Net Cash Flow - Financing3.1M8.3M4.6M--
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.001.0K0.00--
 
 
 
Net Change In Cash-221.1M128.8M-115.8M0.00